Cancer Diagnostic Market Share,Size and Forecast 2019-2026

SKU: DHC255 | Last Updated On: 2019-07-31 | No. of Pages: 189 | Available Formats

( 25 Samples have been requested. )
On July 29th 2019, Exact Sciences and Genomic Health, collaborated for a stock transaction valued at $2.8 billion, joining two of the strongest brands in cancer diagnostics, Cologuard® and Oncotype DX®, providing a strong platform for continued growth.

Global Cancer Diagnostics Market

  1. Global Cancer Diagnostics Market Methodology and Scope

    1. Research Methodology

    2. Research Objective and Scope of the Report

  2. Global Cancer Diagnostics Market – Market Definition and Overview

  3. Global Cancer Diagnostics Market – Executive Summary

    1. Market Snippet by Diagnostic Type

    2. Market Snippet by Application

    3. Market Snippet by End-User

  4. Global Cancer Diagnostics Market Dynamics

    1. Market Impacting Factors

      1. Drivers

        1. Rising Incidence of Cancer Globally

        2. Increasing Technological Advancement

      2. Restraints

        1. The high cost of Diagnostic Systems

        2. Risk related to high radiation exposure affecting the use of CT scanner

      3. Opportunity

      4. Impact Analysis

  5. Global Cancer Diagnostics Market – Industry Analysis

    1. Porter's Five Forces Analysis

    2. Regulatory Analysis

    3. Supply Chain Analysis

    4. Pricing Analysis

  6. Global Cancer Diagnostics Market – By Diagnostic Type

    1. Introduction

      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Type Segment

      2. Market Attractiveness Index, By Diagnostic Type Segment

    2. Tumor Biomarkers*

      1. Introduction

      2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026

    3. Diagnostic Imaging Tests

      1. Magnetic Resonance Imaging (MRI) Scan

      2. Positron Emission Tomography (PET) Scan

      3. Computed Tomography (CT) Scan

      4. Standalone Positron Emission Tomography (SPECT) Scan

      5. Mammography

      6. Ultrasound

      7. Others

    4. Biopsy

    5. Immunohistochemistry (IHC)

    6. in Situ Hybridization (ISH

    7. Next-Generation Sequencing (NGS)

    8. Polymerase Chain Reaction (PCR)

    9. Others

  7. Global Cancer Diagnostics Market – By Application

    1. Introduction

      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment

      2. Market Attractiveness Index, By Application Segment

    2. Lung Cancer*

      1. Introduction

      2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026

    3. Breast Cancer

    4. Liver Cancer

    5. Kidney Cancer

    6. Blood Cancer

    7. Prostate Cancer

    8. Cervical Cancer

    9. Pancreatic Cancer

    10. Skin Cancer

    11. Ovarian Cancer

    12. Others

  8. Global Cancer Diagnostics Market – By End-User

    1. Introduction

      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment

      2. Market Attractiveness Index, By End-User Segment

    2. Hospitals*

      1. Introduction

      2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2026

    3. Diagnostic Imaging Centers

    4. Diagnostic Laboratories

    5. Cancer Research Institutes

    6. Others

  9. Global Cancer Diagnostics Market – By Region

    1. Introduction

      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region

      2. Market Attractiveness Index, By Region

    2. North America

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Type

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. The U.S.

        2. Canada

        3. Mexico

    3. Europe

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Type

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. Germany

        2. The U.K.

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

    4. South America

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Type

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. Brazil

        2. Argentina

        3. Rest of South America

    5. Asia Pacific

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Type

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. China

        2. India

        3. Japan

        4. Australia

        5. Rest of Asia Pacific

    6. The Middle East and Africa

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostic Type

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

  10. Global Cancer Diagnostics Market – Competitive Landscape

    1. Competitive Scenario

    2. Market Positioning/Share Analysis

    3. Mergers and Acquisitions Analysis

  11. Company Profiles

    1. Abbott Laboratories*

      1. Company Overview

      2. Product Portfolio and Description

      3. Key Highlights

      4. Financial Overview

    2. Thermo Fisher Scientific, Inc.

    3. Agilent Technologies Inc.

    4. Qiagen

    5. F. Hoffmann-La Roche Ltd

    6. bioMérieux SA

    7. Biocare Medical, LLC

    8. Danaher Corporation

    9. Illumina Inc.

    10. GE Healthcare

  12. Global Cancer Diagnostics Market – Premium Insights

  13. Global Cancer Diagnostics Market – DataM

    1. Appendix

    2. About Us and Services

    3. Contact Us

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
step 1We collate your requirements.
step 2Our global research team is put into action.
step 3We deliver, and make sure your endeavour is a success!

Buy This Report